Show
Sort by
-
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients
-
- Journal Article
- A1
- open access
New paradigm in NKT cell antigens : MCS-0208 (2-(hydroxymethyl)phenylthio-phytoceramide) - an aryl-phytoceramide compound with a single hydroxyl group stimulates NKT cells
-
Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma
-
Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
-
- Journal Article
- A1
- open access
Tumor PD-L1 status and CD8+ tumor-infiltrating T cells : markers of improved prognosis in oropharyngeal cancer
-
TILs in head and neck cancer : ready for clinical implementation and why (not)?
-
- Journal Article
- A1
- open access
Synthesis of C-5" and C-6"-modified α-GalCer analogues as iNKT-cell agonists
-
- Journal Article
- A1
- open access
An in silico approach for modelling T-helper polarizing iNKT cell agonists
-
- Journal Article
- A1
- open access
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model
-
Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells
-
- Journal Article
- A1
- open access
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection
-
- Conference Paper
- C3
- open access
A computational high-throughput screening approach of iNKT-agonists: a novel tool to find optimized iNKT cell ligands
-
The 3rd anchor model: A study of CD1d-glycolipid mediated iNKT cell activation.
(2012) -
- Conference Paper
- C3
- open access
Versatile synthesis of C-5" and C-6"-modified α-GalCer analogues as new iNKT cell ligands
-
- Journal Article
- A1
- open access
Synthesis of 6”-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands
-
Adjuvantia of de queeste naar het ultieme vaccin
-
Divergent synthetic approach to 6''-modified α-GalCer analogues
-
Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo
-
6''-Modified alpha-GalCer analogs capable of establishing an extra interaction with Cd1d leading to a polarized Th1 response and superior tumor protection
-
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
-
Invariant natural killer T cells in rheumatic disease : a joint dilemma
-
Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid
-
- Journal Article
- A1
- open access
Synthesis and evaluation of amino-modified α-GalCer analogues
-
Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid
-
Suppression of human natural killer T cell function by CD4(+)CD25(+)FOXP3(+) regulatory T cells
-
Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells